Model for Biological Iron Mobilization
J. Am. Chem. Soc., Vol. 123, No. 30, 2001 7255
Hitachi 320A spectrophotometer. CD spectra were taken with a JASCO
J-720 spectrophotometer. HPLC was carried out on a JASCO 880-PU
apparatus combined with 875-UV and 100-III attachments, using a
column (4.6 mm × 250 mm) of CrestPak C18 T-5. A solvent system
of CH3CN-H2O (3:1 v/v) containing 0.1% phosphoric acid and 5 mM
sodium 1-octanesulfonate was applied at a flow rate of 1 mL/min, and
the retention time (Rt) was determined. Mass spectra were determined
on Micromass QUATTRO II equipment. Optical rotations were
4.23 (qn, J ) 7.3, 3H), 4.30 (qn, J ) 7.3, 3H), 4.79 (qn, J ) 7.3, 3H),
7.79 (t, J ) 5.1, 3H), 7.80 (d, J ) 7.2,3H), 7.99 (d, J ) 7.8, 3H), 8.09
(d, J ) 7.0, 3H), 9.95 (s, 3H). Anal. Calcd for C48H84N16O18‚4H2O:
C, 46.29; H, 7.45; N, 18.00. Found: C, 46.49; H, 7.26; N, 18.33.
[Ac-Ala-{Ala-â-(HO)Ala-Ala}2-NHCH2CH2]3N (2). Compound 8a
(0.51 g, 0.31 mmol) in CH2Cl2 (1.0 mL) was treated with TFA (14.3
mL, 187 mmol) at 0 °C for 3.5 h, and the solvent was evaporated. A
residue (8b) in DMSO (10 mL) was condensed with 6a (0.57 g, 1.3
mmol) in DMF (13 mL) in the presence of NMM (0.39 mL, 3.5 mmol)
for 3 h at 0 °C and for 24 h at room temperature by a BOP reagent54
(0.88 g, 2.0 mmol) accompanied with NMM (0.33 mL, 3.0 mmol).
DMF was evaporated, and CHCl3 (100 mL) was added. The mix-
ture was washed with water (2 × 50 mL), 5% aqueous NaHCO3 (3 ×
100 mL), dried (MgSO4), and purified by a Sephadex LH-20 column
(with MeOH) to give a product: {Boc-Ala-[Ala-â-(BnO)Ala-Ala]2-
NHCH2CH2}3N (9a) in 80% (0.64 g): HPLC Rt 8.0 min; IR (KBr,
1
measured with a Horiba SWPA-2000 polarimeter at 25 ( 0.1 °C. H
NMR spectroscopy was performed in CDCl3 at an ambient temperature
or in DMSO-d6 with a JEOL GX-400 or an A-500 spectrometer using
Me4Si as the standard. The melting points are uncorrected. Double-
distilled water was deionized by passing through an ion-exchange resin
(Dowex 50W-X8).
Synthesis. Boc-Ala-Ala-â-(BnO)Ala-OH (6a) was obtained as
previously reported.28
1
cm-1) 1680, 1640, 1540, 1450, 1370, 750, 700; H NMR (CDCl3) δ
(Boc-Ala-NHCH2CH2)3N (7a). To a mixture of Boc-Ala-OH (6.81
g, 36 mmol), HOBt (6.12 g, 40 mmol) and EDC‚HCl (9.59 g, 50 mmol)
in CH2Cl2 (100 mL) was added tris(2-aminoethyl)amine (1.46 g, 10
mmol) in DMSO (10 mL). The mixture was stirred for 3 h at -10 °C
and for 50 h at room temperature, and the solvent was evaporated,
followed by addition of CHCl3 (100 mL). The resulting mixture was
washed with water (2 × 50 mL) and 5% aqueous NaHCO3 (3 × 100
mL) and dried (MgSO4). Evaporation of the solvent and tritiation of
the residue with CHCl3-EtOAc gave crystals of 7a (3.78 g, 57%):
mp 162-163 °C; IR (KBr, cm-1) 3300, 2900, 1700 (CdO Boc), 1670
(CdO amide), 1535 (NH amide), 1370, 1250, 1175; 1H NMR (CDCl3)
δ 1.36 (d, J ) 7.1, 9H), 1.42 (s, 27H), 2.56 (t, 6H), 3.00-3.50 (m,
6H), 4.40 (m, 3H), 5.60 (br d, 3H), 8.78 (br s, 3H).
1.25 (m, 45H), 1.43 (s, 27H), 2.47 (m, 18H), 2.9-3.3 (m, 6H), 3.8-
4.1 (m, 12H), 4.25 (m, 3H), 4.58 (m, 6H), 4.93 (d, J ) 7.1, 12H), 4.95
(m, 6H), 5.38 (br s, 3H), 7.00 (br s, 3H), 7.37 (m, 30H), 7.41 (br s,
6H), 7.60 (d, J ) 6.6, 3H). Compound 9a (0.597 g, 0.232 mmol) in
CH2Cl2 (2.3 mL) and TFA (10.6 mL, 139 mmol) gave 9b, which was
acetylated in DMSO (1.0 mL)-CHCl3 (15 mL) with N-acetoxysuc-
cinimide (0.182 g, 1.16 mmol) and Et3N (0.54 mL) at -10 °C for 3 h
and for 24 h at room temperature. The residue obtained was purified
by a Sephadex LH-20 column (with MeOH) to give a product (0.35 g,
63%): {Ac-Ala-[Ala-â-(BnO)Ala-Ala]2-NHCH2CH2}3N (9c): HPLC
Rt 7.2 min; IR (KBr, cm-1) 1660, 1640, 1540, 1450, 1370, 750, 700;
1H NMR (400 MHz, CDCl3) δ 1.24 (m, 45H), 1.96 (s, 9H), 2.46 (m,
12H), 2.53 (m, 6H, s), 2.9-3.3 (m, 6H), 3.7-4.2 (m, 12H), 4.57 (m,
9H), 4.88 (s, 12H), 4.93 (m, 6H), 6.80 (br s, 3H), 7.28 (br s, 3H), 7.36
(m, 30H), 7.64 (br s, 12H). Compound 9c (0.15 g, 0.063 mmol) in
MeOH (100 mL) was hydrogenated with H2 in the presence of Pd on
carbon (15 mg, 10%) for 20 h at room temperature. The product (2)
was purified with a Sephadex G-15 column to afford a white solid (60
mg, 52%): HPLC Rt 2.1 min; Optical rotation [R]25D -60 (c 0.3, H2O);
IR (KBr, cm-1) 3260 (N-OH), 1640, 1540, 1450 (CONOH); 1H NMR
(DMSO-d6 at 30 °C) δ 1.17 (d, J ) 6.8, 27H), 1.19 (d, J ) 5.4, 18H),
1.83 (s, 9H), 2.40 (t, J ) 6.5, 18H), 3.10 (m, 6H), 3.69 (m, 12H), 4.27
(qn, J ) 7.0, 3H), 4.29 (qn, J ) 7.3, 6H), 4.78 (qn, J ) 6.6, 6H), 7.79
(t, J ) 6.5, 3H), 7.84 (d, J ) 7.3, 6H), 7.98 (d, J ) 7.3, 3H), 8.09 (d,
J ) 7.3, 6H), 9.91 (s, 6H). Anal. Calcd for C75H129N25O30‚6.5H2O: C,
45.54; H, 7.24; N, 17.70. Found: C, 45.68; H, 6.93; N, 17.38.
[Boc-Ala-Ala-â-(BnO)Ala-Ala-NHCH2CH2]3N (8a). Compound 7a
(4.67 g, 7.09 mmol) was treated in TFA (130 mL, 1.7 mol) for 3.5 h
at 0 °C to give tris(CF3CO2H‚H-Ala-NHCH2CH2)N (7b) as an oil with
inclusion of TFA (9.95 g, 7.09 mmol). To a mixture of 6a (11.7 g,
24.8 mmol), HOBt (6.13 g, 40 mmol), and EDC‚HCl (7.67 g, 40 mmol)
in CHCl3 (100 mL) was added dropwise 7b and NMM (7.14 mL) in
DMSO (30 mL) at -10 °C. The mixture was stirred for 3 h at -10 °C
and for 24 h at room temperature, followed by addition of CHCl3 (100
mL). The resulting mixture was washed with water (2 × 200 mL) and
aqueous 5% NaHCO3 (3 × 200 mL) and dried (MgSO4). After
evaporation of the solvent, the residue was purified by silica gel
chromatography with CHCl3-MeOH (5:1 v/v), yielding a product (8a)
(10,4 g, 91%): HPLC Rt 3.0 min; IR (KBr, cm-1) 3300, 2970, 1650,
1
1530, 750, 700; H NMR (DMSO-d6 at 40 °C) δ 1.15 (m, 27H), 1.38
Iron(III) Complex Formation. Stock solutions of 3.05 × 10-3
M
(s, 27H), 2.45 (m, 12H), 3.08 (m, 6H), 3.72-4.04 (m, 6H), 4.05 (m,
3H), 4.28 (m, 3H), 4.85 (m, 3H), 4.95 (ABq, J ) 9.2, 6H), 6.80 (br s,
3H), 7.41 (m, 15H), 7.70 (t, J ) 6.4, 3H), 7.93 (d, J ) 7.3, 3H), 8.05
(d, J ) 7.1, 3H).
and 1.47 × 10-3 M for ligands 1 and 2 in water were prepared. A
stock solution of ferric nitrate (2.93 × 10-3 M) was prepared by
dissolving Fe(NO3)3‚9H2O in 0.1 M nitric acid solution.
(a) In a 10-mm cell held at a constant temperature of 25.0 ( 0.1 °C
in the cell compartment of the spectrophotometer, a solution of 1 (7.84
× 10-7 mol) and a KCl solution were placed and diluted with water.
The total volume was 3.00 mL with 0.10 M KCl. In the case of 2, a
ligand solution (3.9 × 10-7 mol) was used to make a 3.00 mL solution
with 0.10 M KCl. To these was added an iron(III) solution (7.82 ×
10-7 mol). The pH of the solution was determined (pH 2.1 ( 0.1).
For studies at pH 7.0, the pH of the solutions was adjusted with 0.1
M KOH (ca. 0.3 mL). The CD spectrum was determined for this
solution, and the concentration was corrected for added volume.
(b) For pH titration studies, the pH of the above neutral solutions
was adjusted with small quantities of either 0.1 M HNO3 or 0.1 M
KOH. The UV-vis spectra were recorded, and the concentrations of
the resulted solutions were corrected for added volume.
(c) Schwarzenbach plots were generated from these solutions that
exhibited isosbestic behavior in the UV-vis spectra during the pH
titration studies.
NMR Determinations of Gallium(III) Complexes. A 1.5-equiv or
a 1.0-equiv amount of Ga(OH)3, prepared in situ from Ga(NO3)3 and
aqueous alkali, was combined with 1 or 2 in H2O, respectively, stirred
for 24 h, and filtered, and the solution was evaporated. The solid was
dissolved in DMSO-d6.15 Alternatively, Ga1-2 was prepared in situ by
[Ac-Ala-Ala-â-(BnO)Ala-Ala-NHCH2CH2]3N (8c). Compound 8a
(1.62 g, 1.00 mmol) and TFA (20 mL, 240 mmol) in CH2Cl2 (20 mL)
were treated for 3 h at 0 °C, and evaporated. A residue (8b) was treated
with Et3N (4.0 mL) in DMSO (5.0 mL) and N-acetoxysuccinimide53
(0.94 g, 6.0 mmol) in CHCl3 (20 mL) for 3 h at -10 °C and for 50 h
at room temperature and purified by silica gel chromatography with
CHCl3-MeOH (5:1 v/v) to give a compound (8c) in 84% (1.21 g):
1
HPLC Rt 7.7 min; IR (KBr, cm-1) 1650, 1540, 750, 700; H NMR
(DMSO-d6 at 40 °C) δ 1.15 (m, 27H), 1.83 (s, 9H), 2.45 (m, 12H),
3.08 (m, 6H), 3.70-4.00 (m, 6H), 4.32 (m, 6H), 4.85 (s, 3H), 4.95 (m,
6H), 7.40 (m, 15H), 7.71 (t, J ) 6.5, 3H), 7.93 (d, J ) 7.8, 3H), 8.04
(d, J ) 7.8, 3H), 8.08 (d, J ) 7.8, 3H).
[Ac-Ala-Ala-â-(HO)Ala-Ala-NHCH2CH2]3N (1). Compound 8c
(0.40 g, 0.28 mmol) in MeOH (50 mL) was hydrogenated with H2 in
the presence of Pd on carbon (100 mg; 10%) for 24 h and filtered, and
the solvent was evaporated. The product was purified with a Sephadex
LH-20 column to give a white solid (0.20 g, 61%): HPLC Rt 3.8 min;
Optical rotation [R]25 - 83 (c 0.3, H2O); IR (KBr, cm-1) 3300 (N-
D
1
OH), 1650 (CO amide) 1540, 1380, 1120; H NMR (DMSO-d6 at 30
°C) δ 1.17 (d, J ) 7.3, 9H), 1.20 (d, J ) 7.3, 18H), 1.83 (s, 9H), 2.41
(t, J ) 7.0, 6H), 2.50 (br d, J ) 6.5, 6H), 3.10 (m, 6H), 3.71 (m, 6H),
(53) Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett.
1975, 1222-1225.
(54) Lindsay, D. G.; Shall, S. Biochem. J. 1971, 121, 737-745.